Joseph Friedman

Joseph Friedman

Auto-generated profile, based on publicly available information

Joseph Friedman

Department of Psychiatry, University of California, San Diego, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2022 in Drug and Alcohol Dependence
Verified
Journal Article
Closed access
JFJoseph Friedman
Joseph Friedman
FMFernando Montero
Fernando Montero
PBPhilippe Bourgois
Philippe Bourgois
RWRafik Wahbi
Rafik Wahbi
DDDaniel Dye
Daniel Dye
CSChelsea Shover
Chelsea Shover

13 September 2023 in Addiction
Verified
Journal Article
Open access
JFJoseph Friedman
Joseph Friedman
CSChelsea L. Shover
Chelsea L. Shover
Aims: To characterize polysubstance death in the United States during the transition to the fourth wave of the drug overdose crisis. To characterize co‐involved substances in fatal overdose involving synthetic opioids (mainly illicitly manufactured fentanyl analogues) by year, state, and intersectional sociodemographic groups.Design: Population‐based study of national death records.Setting: United States.Participants/cases: All people who died from drug overdose in the United States between 2010 and 2021.Measurements: Percentage of all fatal overdose involving fentanyls, stimulants, and other drugs. Most commonly co‐involved substances in fentanyl overdose by state and year. Percentage of fatal fentanyl overdose co‐involving stimulants by state and year. Percentage of fatal fentanyl overdose co‐involving stimulants by intersectional region, race/ethnicity, age, and sex.Findings: The percent of US overdose deaths involving both fentanyl and stimulants increased from 0.6% (n = 235) in 2010 to 32.3% (34 429) in 2021, with the sharpest rise starting in 2015. In 2010, fentanyl was most commonly found alongside prescription opioids, benzodiazepines, and alcohol. In the Northeast this shifted to heroin‐fentanyl co‐involvement in the mid‐2010s, and nearly universally to cocaine‐fentanyl co‐involvement by 2021. Universally in the West, and in the majority of states in the South and Midwest, methamphetamine‐fentanyl co‐involvement predominated by 2021. The proportion of stimulant involvement in fentanyl‐involved overdose deaths rose in virtually every state 2015–2021. Intersectional group analysis reveals particularly high rates for older Black and African American individuals living in the West.Conclusions: By 2021 stimulants were the most common drug class found in fentanyl‐involved overdoses in every state in the US. The rise of deaths involving cocaine and methamphetamine must be understood in the context of a drug market dominated by illicit fentanyls, which have made polysubstance use more sought‐after and commonplace. The widespread concurrent use of fentanyl and stimulants, as well as other polysubstance formulations, presents novel health risks and public health challenges.

2 March 2022 in JAMA Psychiatry
Verified
Journal Article
Open access
PDF file
JFJoseph R. Friedman
Joseph R. Friedman
HHHelena Hansen
Helena Hansen
Drug overdose mortality rates have increased sharply in the US since the COVID-19 pandemic began in 2020.1 Since 2015, overdose deaths have been rising most rapidly among Black and Hispanic and Latino communities.2 The pandemic has since disproportionately worsened a wide range of health, social, and economic outcomes among racial and ethnic minoritized communities. Careful attention to examining these trends by race and ethnicity is therefore warranted. Here we evaluate increases in drug overdose mortality rates by race and ethnicity before and during the COVID-19 pandemic.

12 April 2022 in JAMA
Verified
Journal Article
Open access
PDF file
JFJoseph Friedman
Joseph Friedman
MGMorgan Godvin
Morgan Godvin
CSChelsea L. Shover
Chelsea L. Shover
JGJoseph P. Gone
Joseph P. Gone
HHHelena Hansen
Helena Hansen
DSDavid L. Schriger
David L. Schriger
The illicit drug supply has increasingly become contaminated with illicitly manufactured fentanyls and other synthetic opioid and benzodiazepine analogues.1 Adolescent drug use rates remained generally stable between 2010 and 2020, with 30.2% and 30.4%, respectively, of 10th-graders reporting any illicit drug use in the past 12 months, which declined to 18.7% of 10th-graders in 2021.2 However, given the increase in illicit fentanyls and potential associated risks, we assessed shifts in overdose deaths among adolescents.

1 July 2021 in American Journal of Public Health
Verified
Journal Article
Closed access
JFJoseph Friedman
Joseph Friedman
SASamir Akre
Samir Akre
Objectives. To determine the magnitude of increases in monthly drug-related overdose mortality during the COVID-19 pandemic in the United States.Methods. We leveraged provisional records from the Centers for Disease Control and Prevention provided as rolling 12-month sums, which are helpful for smoothing, yet may mask pandemic-related spikes in overdose mortality. We cross-referenced these rolling aggregates with previous monthly data to estimate monthly drug-related overdose mortality for January through July 2020. We quantified historical errors stemming from reporting delays and estimated empirically derived 95% prediction intervals (PIs).Results. We found that 9192 (95% PI = 8988, 9397) people died from drug overdose in May 2020—making it the deadliest month on record—representing a 57.7% (95% PI = 54.2%, 61.2%) increase over May 2019. Most states saw large-magnitude increases, with the highest in West Virginia, Kentucky, and Tennessee. We observed low concordance between rolling 12-month aggregates and monthly pandemic-related shocks.Conclusions. Unprecedented increases in overdose mortality occurred during the pandemic, highlighting the value of presenting monthly values alongside smoothed aggregates for detecting shocks.Public Health Implications. Drastic exacerbations of the US overdose crisis warrant renewed investments in overdose surveillance and prevention during the pandemic response and postpandemic recovery efforts.

15 April 2020 in Nature
Verified
Journal Article
Open access
PDF file
JFJoseph Friedman
Joseph Friedman
HYHunter York
Hunter York
NGNicholas Graetz
Nicholas Graetz
LWLauren Woyczynski
Lauren Woyczynski
JWJoanna Whisnant
Joanna Whisnant
EGEmmanuela Gakidou
Emmanuela Gakidou
Education is a key dimension of well-being and a crucial indicator of development1–4. The Sustainable Development Goals (SDGs) prioritize progress in education, with a new focus on inequality5–7. Here we model the within-country distribution of years of schooling, and use this model to explore educational inequality since 1970 and to forecast progress towards the education-related 2030 SDG targets. We show that although the world is largely on track to achieve near-universal primary education by 2030, substantial challenges remain in the completion rates for secondary and tertiary education. Globally, the gender gap in schooling had nearly closed by 2018 but gender disparities remained acute in parts of sub-Saharan Africa, and North Africa and the Middle East. It is predicted that, by 2030, females will have achieved significantly higher educational attainment than males in 18 countries. Inequality in education reached a peak globally in 2017 and is projected to decrease steadily up to 2030. The distributions and inequality metrics presented here represent a framework that can be used to track the progress of each country towards the SDG targets and the level of inequality over time. Reducing educational inequality is one way to promote a fairer distribution of human capital and the development of more equitable human societies.